Syndax Pharmaceuticals (SNDX) Earnings Date, Estimates & Call Transcripts $10.57 +1.27 (+13.66%) As of 05/20/2025 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Syndax Pharmaceuticals Earnings Summary Syndax Pharmaceuticals released Q1 2025 earnings on May 5, 2025, reporting an EPS of -$0.98, which topped the consensus estimate of -$1.04 by $0.06. Quarterly revenue rose 1900.0% year-over-year to $20.04 million, above analysts' expectations of $15.88 million. With a trailing EPS of -$3.86, Syndax Pharmaceuticals' earnings are expected to decrease next year, from ($3.72) to ($4.25) per share. Upcoming Q2 Earnings DateAug. 7After Market ClosesEstimatedConsensus EPS (May. 5) -$1.04 Actual EPS (May. 5) -$0.98 Beat By $0.06 Actual Revenue (May. 5) $20.04MQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q) Slide DeckSNDX Upcoming EarningsSyndax Pharmaceuticals' next earnings date is estimated for Thursday, August 7, 2025, based on past reporting schedules. Slide DeckFull Screen Slide DeckPowered by Get Syndax Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Syndax Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataSNDX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SNDX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Syndax Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$1.11-$1.00-$1.06Q2 20252-$0.98-$0.93-$0.96Q3 20252-$0.95-$0.81-$0.88Q4 20252-$0.92-$0.62-$0.77 Syndax Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/7/2025(Estimated)--------5/5/2025Q1 2025-$1.04-$0.98+$0.06-$0.98$15.88M$20.04M3/3/2025Q4 2024-$0.31-$1.10 -$0.79-$1.10$86.32M$7.68M11/5/2024Q3 2024-$1.13-$0.98+$0.15-$0.98$9.16M$12.50M8/1/2024Q2 2024-$0.91-$0.80+$0.11-$0.80-$3.50M5/8/2024Q1 2024-$0.96-$0.85+$0.11-$0.85--2/27/2024Q4 2023-$0.99-$1.00 -$0.01-$1.00--11/2/2023Q3 2023-$0.80-$0.73+$0.07-$0.73--8/3/2023Q2 2023-$0.73-$0.64+$0.09-$0.64-- Syndax Pharmaceuticals Earnings - Frequently Asked Questions When is Syndax Pharmaceuticals's earnings date? Syndax Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 7th, 2025 based off last year's report dates. Learn more on SNDX's earnings history. Did Syndax Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Syndax Pharmaceuticals (NASDAQ:SNDX) reported ($0.98) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.04) by $0.06. Learn more on analysts' earnings estimate vs. SNDX's actual earnings. How can I listen to Syndax Pharmaceuticals's earnings conference call? The conference call for Syndax Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Syndax Pharmaceuticals's conference call transcript? The conference call transcript for Syndax Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Syndax Pharmaceuticals generate each year? Syndax Pharmaceuticals (NASDAQ:SNDX) has a recorded annual revenue of $43.72 million. How much profit does Syndax Pharmaceuticals generate each year? Syndax Pharmaceuticals (NASDAQ:SNDX) has a recorded net income of -$209.36 million. SNDX has generated -$3.86 earnings per share over the last four quarters. What is Syndax Pharmaceuticals's EPS forecast for next year? Syndax Pharmaceuticals's earnings are expected to decrease from ($3.72) per share to ($4.25) per share in the next year. More Earnings Resources from MarketBeat Related Companies RYTM Earnings Results PTCT Earnings Results SRPT Earnings Results RNA Earnings Results SWTX Earnings Results RARE Earnings Results AKRO Earnings Results ACLX Earnings Results ZLAB Earnings Results VKTX Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba's Earnings Just Changed Everything for the StockCisco Stock Eyes New Highs in 2025 on AI, Earnings, UpgradesSymbotic Gets Big Earnings Lift: Is the Stock Investable Again?D-Wave Pushes Back on Short Seller Case With Strong EarningsAppLovin Surges on Earnings: What's Next for This Tech Standout?Can Shopify Stock Make a Comeback After an Earnings Sell-Off?Rocket Lab: Earnings Miss But Neutron Momentum Holds This page (NASDAQ:SNDX) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Syndax Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Syndax Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SNDX Stock Free SNDX Stock Alerts